Locations:

Tag: cardiovascular prevention

Lp(a) particles floating among red blood cells

April 1, 2025/Heart, Vascular and Thoracic/Preventive Cardiology

Lepodisiran’s Large, Durable Lp(a) Reductions in Phase 2 Trial Boost Anticipation of Phase 3 Results

Small interfering RNA lowered lipoprotein(a) by 94% during six-month follow-up after a single dose

23-HVI-3606660_LDL-cholesterol-particles_650x450

March 4, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

CLEAR Outcomes: Bempedoic Acid Reduces Cardiovascular Events in Statin-Intolerant Patients

Findings bolster the oral drug as an option for primary and secondary prevention

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy